Intermittent Fasting for Pancreatitis

Launched by H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE · Feb 15, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at whether intermittent fasting, which is a type of eating pattern where you alternate between eating and not eating, can help improve the quality of life for people with pancreas-related diseases, such as pancreatitis. The goal is to see if this approach can reduce symptoms and lower the chances of needing to go to the hospital for problems linked to the pancreas.

To participate in this study, you need to be at least 18 years old and have experienced multiple episodes of pancreatitis. This means having significant abdominal pain along with certain lab test results or imaging that shows damage to the pancreas. You will not be eligible if you are under 18, pregnant, over 80, or have certain other health conditions, like diabetes or active alcohol abuse. If you join the trial, you can expect to follow either an intermittent fasting plan or a standard diet, and researchers will monitor your health and symptoms throughout the study. This trial is not yet recruiting participants, but it aims to offer new insights into managing pancreas diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 year
• * Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by:
• • abdominal pain and either amylase or lipase \> 3 x the upper limit of normal, imaging suggestive of, separated by time
• • Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
• • Pancreatic exocrine insufficiency defined by a pancreatic elastase \< 200 ug/g stool10
• Exclusion Criteria:
• • Age \< 18 years
• • Pregnant Patients
• • Age \> 80 years
• • Patients who cannot consent for themselves
• • Glycogen storage disease
• • Insulinoma or hypoglycemic state
• • Active alcohol abuse
• • Alcohol induced acute pancreatitis
• • Gallstone induced acute pancreatitis
• • Pancreatic solid neoplasm
• • Patients with diabetes
• • Patients on beta blockers